If you are wondering whether Siemens Healthineers at €40.86 is a bargain or a value trap, this article will help you frame ...

Siemens Healthineers announced that it agreed to expand its strategic collaboration with Mayo Clinic to enhance patient care.

By Maria Rugamer and Orest Dovhan Feb 5 (Reuters) - Siemens Healthineers posted mixed first‑quarter results on Thursday, ...

Siemens Aktiengesellschaft (ETR:SIE) opened its 2026 Annual Shareholders’ Meeting in Munich with Supervisory Board Chairman ...

Mayo Clinic Siemens expand AI collaboration to enhance imaging and digital twin technologies for neurodegenerative diseases and cancer care.

Northwestern Medicine and Siemens aim to improve the treatment experience for cancer patients, from shorter wait times to ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Siemens Healthineers and the fast-growing startup Medically Home are ...

An expanded collaboration between the two organizations will focus on prostate cancer and metastatic liver tumors, in addition to certain neurological disorders.

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, ...

Siemens Healthineers reported first-quarter operating profit above market expectations on Thursday, as strong margin ...

Siemens Healthineers reported good revenue growth and margin expansion in Q2 2024, with strong performance in Imaging, Varian, and Advanced Therapies segments. Despite a recent decline in share price, ...

Deal Overview On October 2, 2025, reports surfaced that Siemens AG (US OTC: SIEGY ADR, $142.89; Market Capitalization: $228.6 billion) is actively evaluating a potential spin-off of a substantial ...